Projects per year
Fingerprint Dive into the research topics where Paul Mullan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 64 Similar Profiles
Breast Neoplasms
Medicine & Life Sciences
asparaginylendopeptidase
Medicine & Life Sciences
DNA Damage
Medicine & Life Sciences
Ovarian Neoplasms
Medicine & Life Sciences
Biomarkers
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Triple Negative Breast Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2012 2018
R3511CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB
Harrison, T., Harkin, D., Johnston, P., Kennedy, R., Longley, D., Mullan, P., Prise, K., Salto-Tellez, M., Waugh, D., Williams, R. & Wilson, R.
01/08/2012 → 30/04/2016
Project: Research
R1289CNR: Development of a Biomarker for the SRC Pathway in Ovarian Cancer
01/08/2012 → 28/03/2015
Project: Research
R5771CNR: Establishment of an Integrated Almac-QUB Drug Discovery Unit at CCRCB
Waugh, D., Harkin, D., Johnston, P., Kennedy, R., Longley, D., Mullan, P., O'Sullivan, J., Prise, K., Salto-Tellez, M., Williams, R. & Wilson, R.
01/08/2012 → 30/04/2016
Project: Research
Research Output 2000 2019
Defining the molecular evolution of extrauterine high grade serous carcinoma
Beirne, J. P., McArt, D. G., Roddy, A., McDermott, C., Ferris, J., Buckley, N. E., Coulter, P., McCabe, N., Eddie, S. L., Dunne, P. D., O'Reilly, P., Gilmore, A., Feeney, L., Ewing, D. L., Drapkin, R. I., Salto-Tellez, M., Kennedy, R. D., Harley, I. J. G., McCluggage, W. G. & Mullan, P. B., 04 Sep 2019, In : Gynecologic Oncology. 155, 2, p. 305-317 13 p.Research output: Contribution to journal › Article
Molecular Evolution
Carcinoma
Fallopian Tubes
Carcinoma in Situ
Epithelium
Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal crypt
Dutton, L. R., Hoare, O. P., McCorry, A. M. B., Redmond, K. L., Adam, N. E., Canamara, S., Bingham, V., Mullan, P. B., Lawler, M., Dunne, P. D. & Brazil, D. P., 23 Jul 2019, In : Oncotarget. 10, 45, p. 4630-4639 10 p.Research output: Contribution to journal › Article
Open Access
File
Tumor Microenvironment
Colorectal Neoplasms
Fibroblasts
Epithelial Cells
Bone Morphogenetic Proteins
Identification and SAR exploration of a novel series of Legumain inhibitors
Eddie, S. L., Gregson, A., Graham, E., Burton, S., Harrison, T., Burden, R., Scott, C. J., Mullan, P. B. & Williams, R., 15 Jun 2019, In : Bioorganic & Medicinal Chemistry Letters. 29, 12, p. 1546-1548 3 p.Research output: Contribution to journal › Article
asparaginylendopeptidase
Dipeptides
Molecules
Research
Experiments
NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer
Mullan, P. B., Bingham, V., Haddock, P., Irwin, G. W., Kay, E., McQuaid, S. & Buckley, N. E., 02 Apr 2019, In : BMC Cancer. 19, 13 p., 236.Research output: Contribution to journal › Article
Open Access
File
Triple Negative Breast Neoplasms
Anthracyclines
Drug Therapy
Standard of Care
Biomarkers
TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells
Crawford, N. T., McIntyre, A. J., McCormick, A. J., D'Costa, Z. C., Buckley, N. E. & Mullan, P. B., 28 Jun 2019, In : Oncogene.Research output: Contribution to journal › Article
Breast Neoplasms
Growth
Protein Binding
Cell Proliferation
Co-Repressor Proteins
Impact
Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation
Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant), Daniel Longley (Participant)
Impact: Health Impact, Quality of Life Impact